Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

INTRODUCTION: Remission induction in antineutrophil cytoplasmic autoantibody (ANCA) vasculitis may be complicated by slow response to treatment and toxicity from glucocorticoids. We describe outcomes with a novel remission induction regimen combining rituximab with a short course of low-dose, oral c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortazar, Frank B., Muhsin, Saif A., Pendergraft, William F., Wallace, Zachary S., Dunbar, Colleen, Laliberte, Karen, Niles, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932132/
https://www.ncbi.nlm.nih.gov/pubmed/29725643
http://dx.doi.org/10.1016/j.ekir.2017.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932132/
https://www.ncbi.nlm.nih.gov/pubmed/29725643
http://dx.doi.org/10.1016/j.ekir.2017.11.004

Ejemplares similares